CreativeOne Wealth LLC Has $1.85 Million Holdings in CME Group Inc. (NASDAQ:CME)

CreativeOne Wealth LLC increased its stake in shares of CME Group Inc. (NASDAQ:CME) by 215.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 8,389 shares of the financial services provider’s stock after acquiring an additional 5,731 shares during the period. CreativeOne Wealth LLC’s holdings in CME Group were worth $1,851,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Truvestments Capital LLC bought a new stake in CME Group during the third quarter valued at about $26,000. Y.D. More Investments Ltd bought a new stake in CME Group during the 2nd quarter valued at approximately $36,000. Thurston Springer Miller Herd & Titak Inc. boosted its stake in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares during the period. McClarren Financial Advisors Inc. grew its holdings in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares during the last quarter. Finally, Asset Dedication LLC increased its position in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares during the period. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling at CME Group

In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 5.38 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the completion of the transaction, the insider now directly owns 27,053 shares in the company, valued at $6,131,291.92. This trade represents a 14.26 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,028 shares of company stock worth $1,811,681. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on CME. Morgan Stanley upped their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Oppenheimer increased their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. The Goldman Sachs Group increased their price target on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. TD Cowen started coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target for the company. Finally, Piper Sandler increased their price target on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $224.47.

CME Group Trading Up 1.3 %

Shares of CME Group stock opened at $237.33 on Friday. The stock has a market capitalization of $85.52 billion, a P/E ratio of 24.96, a price-to-earnings-growth ratio of 5.29 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a 50-day simple moving average of $225.05 and a 200 day simple moving average of $211.73. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $238.12.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter last year, the company posted $2.25 EPS. Research analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a $1.15 dividend. This represents a $4.60 annualized dividend and a yield of 1.94%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is presently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.